ProPhase Labs to Present at The ThinkEquity Conference
12 oct. 2023 08h00 HE
|
ProPhase Labs, Inc.
GARDEN CITY, NY, Oct. 12, 2023 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a next generation biotech, genomics, therapeutics and diagnostics company, today announced it will be...
ProPhase Labs Announces Updated Conference Call Dial-in Information for Thursday August 10, 2023 at 11:00 a.m. Eastern Time for Second Quarter 2023 Financial Results Call.
10 août 2023 10h40 HE
|
ProPhase Labs, Inc.
Garden City, NY, Aug. 10, 2023 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) Conference Call and Webcast Details Management will host a conference call at 11:00 AM ET, Thursday, August...
ProPhase Labs Announces Financial Results for the Three Months Ended June 30, 2023
10 août 2023 08h00 HE
|
ProPhase Labs, Inc.
Company believes that the combined value of its five operating units exceeds its current market capitalization and that each unit has significant growth potential. Company highlights...
ProPhase Labs Teams up with Certis Oncology to Accelerate Development of Novel Linebacker Compound
03 août 2023 08h00 HE
|
ProPhase Labs, Inc.
Garden City, NY, Aug. 03, 2023 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase”), a next generation biotech, genomics, therapeutics and diagnostics company, today provided an...
ProPhase Labs to Host Second Quarter 2023 Financial Results Conference Call on Thursday, August 10, 2023 at 11:00 a.m. Eastern Time
02 août 2023 08h00 HE
|
ProPhase Labs, Inc.
GARDEN CITY, NY, Aug. 02, 2023 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a next generation biotech, genomics, therapeutics and diagnostics company, will hold a conference call on...
Navidea Biopharmaceuticals Rejects ProPhase Labs Offer To Acquire Certain Assets of Navidea
29 juin 2023 08h00 HE
|
ProPhase Labs, Inc.
Garden City, NY, June 29, 2023 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase”), a next generation biotech, genomics and diagnostics company, today announced that it recently made...
ProPhase Labs Inc. Sets the Course for Expansion into the MENA Region with Cutting-Edge Genomic and Diagnostics Technologies
22 juin 2023 08h30 HE
|
ProPhase Labs, Inc.
In a bid to seize substantial strategic growth opportunities in an emerging healthcare market, Company reveals plans to increase its global footprint. Garden City, NY, June 22, 2023 (GLOBE...
ProPhase Labs to Present at the Diamond Equity Research Emerging Growth Invitational on Tuesday, June 13, 2023
07 juin 2023 08h00 HE
|
ProPhase Labs, Inc.
Garden City, NY, June 07, 2023 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase”), a next generation biotech, genomics and diagnostics company, today announced that management will...
ProPhase Labs’ Cancer Therapeutic, Linebacker-1, pre-clinical studies with Dana Farber/Harvard Cancer Institute demonstrate impressive utility and move into next phase of testing
01 juin 2023 08h30 HE
|
ProPhase Labs, Inc.
Linebacker fully inhibited lung cancer cell growth and significantly limited colon cancer cell growth in two separate clonogenic models Development ahead of schedule with mice studies well underway...
ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2023
11 mai 2023 08h00 HE
|
ProPhase Labs, Inc.
As revenue mix transitions, Company still achieves positive net income and significant adjusted EBITDA while acquiring and developing biotech, genomics and diagnostic assets with multi-billion-dollar...